Search
forResearch 10 of 348
- Treatment of Alopecia Areata With Squaric Acid Dibutylester
- Treatment of alopecia areata with squaric acid dibutylester
- Discoid lupus erythematosus exacerbated by contact dermatitis caused by use of squaric acid dibutylester for topical immunotherapy in a patient with alopecia areata
- Topical use of calcipotriol does not potentiate squaric acid dibutylester effectiveness in the treatment of alopecia areata
- Hapten‐induced lymphadenosis benigna cutis secondary to squaric acid dibutylester sensitization for alopecia areata
- Severe pustular lesions induced by topical immunotherapy with squaric acid dibutylester for alopecia totalis
- Squaric Acid Dibutylester Promotes Innate Immune-Driven Hair Growth with CD206+ Macrophage Accumulation in the Dermis
- 965 The importance of CD206+ macrophages in squaric acid dibutylester-induced hair cycle activation
- 440 Squaric acid dibutylester, used in alopecia areata immunotherapy, promotes innate immune-driven hair growth with CD206+ macrophage accumulation in the dermis
- Childhood epidermolysis bullosa acquisita during squaric acid dibutyl ester immunotherapy for alopecia areata
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →